Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
García-Quintanilla L, Almuiña-Varela P, Maroñas O, Gil-Rodriguez A, Rodríguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gómez-Ulla de Irazazabal F, González-Barcia M, Mondelo-Garcia C, Cruz R, Estany-Gestal A, Fernández-Rodríguez M, Fernández-Ferreiro A. García-Quintanilla L, et al. Among authors: gonzalez barcia m. Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):34. doi: 10.1167/iovs.64.13.34. Invest Ophthalmol Vis Sci. 2023. PMID: 37862026 Free PMC article.
In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A, González Barcia M, Gil-Martínez M, Vieites-Prado A, Lema I, Argibay B, Blanco Méndez J, Lamas MJ, Otero-Espinar FJ. Fernández-Ferreiro A, et al. Eur J Pharm Biopharm. 2015 Aug;94:342-51. doi: 10.1016/j.ejpb.2015.06.003. Epub 2015 Jun 14. Eur J Pharm Biopharm. 2015. PMID: 26079831
Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention.
Fernández-Ferreiro A, Santiago-Varela M, Gil-Martínez M, Parada TG, Pardo M, González-Barcia M, Piñeiro-Ces A, Rodríguez-Ares MT, Blanco-Mendez J, Lamas MJ, Otero-Espinar FJ. Fernández-Ferreiro A, et al. Int J Pharm. 2015 Nov 30;495(2):680-91. doi: 10.1016/j.ijpharm.2015.09.058. Epub 2015 Sep 28. Int J Pharm. 2015. PMID: 26423177
[Ophthalmic formulations new goals].
Fernández-Ferreiro A, González-Barcia M, Otero Espinar FJ, Blanco Méndez J, Lamas MJ. Fernández-Ferreiro A, et al. Farm Hosp. 2016 Jan 1;40(1):1-2. doi: 10.7399/fh.2016.40.1.10417. Farm Hosp. 2016. PMID: 26882828 Spanish. No abstract available.
Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations.
Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodriguez A, Vieites-Prado A, Sobrino T, Herranz M, García-Varela L, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Medín-Aguerre S, Pardo-Montero J, Aguiar P. Fernández-Ferreiro A, et al. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):772-780. doi: 10.1167/iovs.16-20766. Invest Ophthalmol Vis Sci. 2017. PMID: 28146242
In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodríguez A, Vieites-Prado A, Lema I, Herranz M, Gómez-Lado N, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Cortes J, Sánchez-Martínez M, Pardo-Montero J, Aguiar P. Fernández-Ferreiro A, et al. Eur J Pharm Biopharm. 2017 May;114:317-323. doi: 10.1016/j.ejpb.2017.01.023. Epub 2017 Feb 9. Eur J Pharm Biopharm. 2017. PMID: 28189624
66 results